Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.
BörsenkürzelMOVE
Name des UnternehmensMovano Inc
IPO-datumMar 23, 2021
CEODr. John Mastrototaro, Ph.D.
Anzahl der mitarbeiter32
WertpapierartOrdinary Share
GeschäftsjahresendeMar 23
Addresse6800 Koll Center Parkway
StadtPLEASANTON
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl94566
Telefon14083931209
Websitehttps://movanohealth.com/
BörsenkürzelMOVE
IPO-datumMar 23, 2021
CEODr. John Mastrototaro, Ph.D.
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten